These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 32059759)

  • 1. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.
    Ortega JA; Daley EL; Kour S; Samani M; Tellez L; Smith HS; Hall EA; Esengul YT; Tsai YH; Gendron TF; Donnelly CJ; Siddique T; Savas JN; Pandey UB; Kiskinis E
    Neuron; 2020 Apr; 106(1):90-107.e13. PubMed ID: 32059759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction.
    Zaepfel BL; Zhang Z; Maulding K; Coyne AN; Cheng W; Hayes LR; Lloyd TE; Sun S; Rothstein JD
    Cell Rep; 2021 Mar; 34(13):108925. PubMed ID: 33789100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of nonsense-mediated mRNA decay protects against C9orf72 dipeptide-repeat neurotoxicity.
    Xu W; Bao P; Jiang X; Wang H; Qin M; Wang R; Wang T; Yang Y; Lorenzini I; Liao L; Sattler R; Xu J
    Brain; 2019 May; 142(5):1349-1364. PubMed ID: 30938419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD.
    Coyne AN; Rothstein JD
    Acta Neuropathol Commun; 2021 Mar; 9(1):45. PubMed ID: 33741069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.
    Ramesh N; Daley EL; Gleixner AM; Mann JR; Kour S; Mawrie D; Anderson EN; Kofler J; Donnelly CJ; Kiskinis E; Pandey UB
    Acta Neuropathol Commun; 2020 Oct; 8(1):177. PubMed ID: 33129345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models.
    Yuva-Aydemir Y; Almeida S; Gao FB
    Trends Neurosci; 2018 Jul; 41(7):457-469. PubMed ID: 29729808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD.
    Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z
    Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
    Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
    Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C9orf72 arginine-rich dipeptide repeats inhibit UPF1-mediated RNA decay via translational repression.
    Sun Y; Eshov A; Zhou J; Isiktas AU; Guo JU
    Nat Commun; 2020 Jul; 11(1):3354. PubMed ID: 32620797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD.
    Yuva-Aydemir Y; Almeida S; Krishnan G; Gendron TF; Gao FB
    Nat Commun; 2019 Nov; 10(1):5466. PubMed ID: 31784536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD.
    Park J; Lee J; Kim JH; Lee J; Park H; Lim C
    Nucleic Acids Res; 2021 Nov; 49(19):11294-11311. PubMed ID: 34551427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
    Fu X; Zhang Z; Hayes LR; Wright N; Asbury J; Li S; Ye Y; Sun S
    Exp Neurol; 2024 Jun; 376():114768. PubMed ID: 38556190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids.
    van der Geest AT; Jakobs CE; Ljubikj T; Huffels CFM; Cañizares Luna M; Vieira de Sá R; Adolfs Y; de Wit M; Rutten DH; Kaal M; Zwartkruis MM; Carcolé M; Groen EJN; Hol EM; Basak O; Isaacs AM; Westeneng HJ; van den Berg LH; Veldink JH; Schlegel DK; Pasterkamp RJ
    Acta Neuropathol Commun; 2024 Sep; 12(1):152. PubMed ID: 39289761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
    Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.
    Li S; Wu Z; Tantray I; Li Y; Chen S; Dong J; Glynn S; Vogel H; Snyder M; Lu B
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25104-25115. PubMed ID: 32958650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro.
    Meijboom KE; Abdallah A; Fordham NP; Nagase H; Rodriguez T; Kraus C; Gendron TF; Krishnan G; Esanov R; Andrade NS; Rybin MJ; Ramic M; Stephens ZD; Edraki A; Blackwood MT; Kahriman A; Henninger N; Kocher JA; Benatar M; Brodsky MH; Petrucelli L; Gao FB; Sontheimer EJ; Brown RH; Zeier Z; Mueller C
    Nat Commun; 2022 Oct; 13(1):6286. PubMed ID: 36271076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Shpilyukova YA; Fedotova EY; Abramycheva NY; Kochergin IA; Zakroyshchikova IV; Zakharova MN; Illarioshkin SN
    Bull Exp Biol Med; 2020 Sep; 169(5):673-676. PubMed ID: 32990847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.